Phlebotomists protect themselves from bloodborne pathogens through a layered system of precautions: treating every blood sample as potentially infectious, wearing the right protective equipment, using safety-engineered needles, getting vaccinated against hepatitis B, and following strict protocols for sharps disposal and specimen handling. These measures aren’t optional suggestions. They’re required by federal law under OSHA’s Bloodborne Pathogens Standard (1910.1030), and every employer with exposed workers must maintain a written plan for carrying them out.
Why These Protections Matter
The risks from a single needlestick aren’t abstract. If the source patient carries hepatitis B, a non-immunized phlebotomist faces a 6 to 24 percent chance of infection from one percutaneous exposure. Hepatitis C transmits at a rate of roughly 1.8 percent per needlestick (with a range of 0 to 7 percent depending on the circumstances). HIV carries a lower but real risk of about 0.3 percent per percutaneous exposure. Hepatitis B is by far the most transmissible of the three, which is exactly why vaccination is the first line of defense.
Universal Precautions: The Foundational Rule
The single most important mindset in phlebotomy is universal precautions. This means treating all human blood and certain body fluids as if they are known to be infectious for HIV, hepatitis B, hepatitis C, and other bloodborne pathogens. You don’t wait for a patient’s test results or medical history to decide whether to be careful. Every draw, every tube, every bandage gets the same level of caution.
When it’s difficult or impossible to tell what type of body fluid you’re dealing with, OSHA requires that all body fluids be treated as potentially infectious. This eliminates guesswork and protects phlebotomists from exposures that might otherwise seem low-risk.
Personal Protective Equipment
Gloves are required for all phlebotomies outside of volunteer blood donation centers. That’s not a best practice; it’s a regulatory mandate. Even at blood donation centers, gloves become mandatory if the phlebotomist has any cuts, scratches, or breaks in their skin, if they’re still in training, or if they believe hand contamination could occur. Gloves create a barrier between the skin and blood, reducing direct contact if a tube leaks, a site bleeds more than expected, or a splash occurs during needle removal.
Eye protection, masks, and face shields come into play when there’s a reasonable chance of splashes, sprays, or droplets reaching the eyes, nose, or mouth. Routine venipuncture in a calm patient rarely calls for this level of protection, but certain situations (an uncooperative patient, a difficult draw, or arterial blood collection) can raise the risk. Protective gowns, lab coats, or aprons are worn when blood could contact the phlebotomist’s clothing or skin on the torso. The general principle is straightforward: match the level of PPE to the realistic hazards of the procedure you’re about to perform.
Safety-Engineered Needles and Devices
Modern phlebotomy equipment is designed to reduce needlestick injuries through built-in safety mechanisms. These devices fall into two main categories: needle-shielding systems, where a protective cover slides over or snaps around the needle after use, and needle-retraction systems, where the needle pulls back into the device body automatically.
Research published in Frontiers in Medical Technology found that retraction devices tend to perform better than shielding devices in practical testing. One shielding device in the study had significant handling problems because users accidentally triggered the spring mechanism while removing the needle cap, before they even started the puncture. Importantly, most needlestick injuries with safety devices happen before or during activation of the safety mechanism, not after. This means the design of the activation step matters enormously, and devices that can be activated with one hand tend to be safer since the phlebotomist doesn’t need to reposition their grip near the exposed needle.
OSHA requires employers to actively evaluate and adopt commercially available safety devices, and to involve frontline phlebotomists in selecting them. If you’re a phlebotomist and your facility is choosing new equipment, your employer is legally required to solicit your input.
Hepatitis B Vaccination
Employers must offer the hepatitis B vaccine series to every worker with occupational exposure to blood, at no cost and at a reasonable time and place. This offer must come within 10 days of an employee’s initial assignment to a role involving blood contact, and only after the worker has received training about the vaccine’s safety, efficacy, and benefits.
You can decline the vaccine, but your employer will ask you to sign a declination form. If you change your mind later, the vaccine must still be provided at no cost as long as you remain in a role with occupational exposure. Given that hepatitis B has the highest transmission rate of any common bloodborne pathogen (up to 24 percent from a single needlestick), vaccination is one of the most effective protections a phlebotomist can have. The vaccine series, once completed and confirmed through antibody testing, provides long-lasting immunity.
Sharps Disposal
Used needles are never recapped, bent, or removed by hand. They go directly into a sharps disposal container, which is a rigid, puncture-resistant box made of plastic or metal with leak-resistant sides, a tight-fitting lid, and an opening large enough for a needle but too small for a hand to reach inside. These containers are placed within easy reach of the draw area so there’s no need to carry an exposed needle across a room.
Each container has a fill line marked at three-quarters capacity. Once the contents reach that line, the container gets closed, sealed, and replaced. Overfilling sharps containers is one of the most preventable causes of needlestick injuries, since needles protruding past the opening or jamming the lid create exactly the kind of accidental contact the container is meant to prevent.
Specimen Handling and Transport
After blood is drawn, the tubes themselves become a potential exposure source. If a primary specimen container could leak during handling, storage, or transport, it must go into a secondary container. OSHA requires this second container to be closable, constructed to contain all its contents and prevent leakage, and properly labeled or color-coded with the biohazard symbol. In practice, this often looks like placing blood tubes into a sealed bag with a separate pouch for paperwork, ensuring that a cracked or loosened cap won’t result in blood contacting anyone who handles the specimen downstream.
The Exposure Control Plan
Every employer covered by the Bloodborne Pathogens Standard must maintain a written Exposure Control Plan. This document spells out which job roles have exposure risk, what specific protections are in place, how hepatitis B vaccination is offered, how hazards are communicated to employees, and what records are kept. The plan isn’t a one-time document. It must be reviewed and updated at least annually to reflect new tasks, new job positions, and changes in available safety technology.
For phlebotomists, this plan is your reference point for understanding exactly what your employer is required to provide and what procedures you’re expected to follow. If your facility hasn’t updated its plan recently or hasn’t involved frontline staff in evaluating safety devices, that’s a compliance gap worth raising.
What Happens After an Exposure
Even with every precaution in place, accidents happen. If a phlebotomist experiences a needlestick or blood splash to mucous membranes, the clock starts immediately. The exposure site should be washed thoroughly (with soap and water for skin, or flushed with water for eyes and mucous membranes), and the incident reported right away.
Medical evaluation needs to happen quickly. For potential HIV exposure, post-exposure prophylaxis (PEP) is only effective if started within 72 hours, and sooner is better. The first dose can be given before all test results come back. The evaluation typically includes a rapid HIV test, hepatitis B and C testing, liver and kidney function tests, and a pregnancy test if relevant. If the source patient can be tested, their results help guide treatment decisions, but waiting for those results should never delay starting PEP when it’s indicated.
Employers are required to provide this post-exposure evaluation and follow-up at no cost to the worker, and to document the circumstances of the incident as part of their Exposure Control Plan. A healthcare professional must provide a written opinion within 15 days of completing the evaluation, covering what follow-up is recommended and whether any treatment was administered.